HCW Biologics Inc. reported $54K in revenue and a $8.0M net loss for fiscal 2025. See the full HCWB financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

[EFFECT] HCW Biologics Inc. SEC Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

EFFECT

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/01/2026 - 06:10 AM Accepted by SEC EDGAR 09/01/2026 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 31, 2026 3:00 P.M.

Form:

S-1

CIK:	0001828673
Company Name:	HCW Biologics Inc.
File Number:	333-298452

Source: View Original Filing on SEC EDGAR